I, A. N., & C, H. (2026). Targeted treatment of anemia in myelofibrosis and the impact of JAK inhibitors. Expert opinion on pharmacotherapy, 27(8), 657. https://doi.org/10.1080/14656566.2026.2671877
Chicago Style (17th ed.) CitationI, Al Noumani, and Harrison C. "Targeted Treatment of Anemia in Myelofibrosis and the Impact of JAK Inhibitors." Expert Opinion on Pharmacotherapy 27, no. 8 (2026): 657. https://doi.org/10.1080/14656566.2026.2671877.
MLA (9th ed.) CitationI, Al Noumani, and Harrison C. "Targeted Treatment of Anemia in Myelofibrosis and the Impact of JAK Inhibitors." Expert Opinion on Pharmacotherapy, vol. 27, no. 8, 2026, p. 657, https://doi.org/10.1080/14656566.2026.2671877.
Warning: These citations may not always be 100% accurate.